Literature DB >> 8549622

Electrical and mechanical responses produced by nerve stimulation in detrusor smooth muscle of the guinea-pig.

H Hashitani1, H Suzuki.   

Abstract

In smooth muscles of the guinea-pig bladder, intramural nerve stimulation generated an excitatory junctional potential (e.j.p.), action potential and twitch contraction. Nicardipine inhibited the action potential but not the e.j.p. The e.j.p. amplitude was reduced by suramin, or desensitization of the ATP receptor with receptor agonists. The amplitude of the twitch contraction was reduced by atropine, and the remainder was blocked by nicardipine. In the presence of maximally effective concentrations of atropine, the threshold concentration of acetylcholine required to produce contraction was about 10(-7) M, whereas acetylcholine concentrations greater than 10(-6) M were required to cause depolarization. It is concluded that nerve stimulation releases acetylcholine and ATP, and the former produces contraction without change in the membrane potential, while the latter generates the e.j.p. which triggers an action potential and thus elicits contractions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8549622     DOI: 10.1016/0014-2999(95)00386-y

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  14 in total

1.  The role of the L-type Ca(2+) channel in refilling functional intracellular Ca(2+) stores in guinea-pig detrusor smooth muscle.

Authors:  C Wu; G Sui; C H Fry
Journal:  J Physiol       Date:  2002-01-15       Impact factor: 5.182

2.  Effects of Ca2+ concentration and Ca2+ channel blockers on noradrenaline release and purinergic neuroeffector transmission in rat tail artery.

Authors:  J A Brock; T C Cunnane
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

3.  Pharmacological activation of small conductance calcium-activated potassium channels with naphtho[1,2-d]thiazol-2-ylamine decreases guinea pig detrusor smooth muscle excitability and contractility.

Authors:  Shankar P Parajuli; Rupal P Soder; Kiril L Hristov; Georgi V Petkov
Journal:  J Pharmacol Exp Ther       Date:  2011-10-14       Impact factor: 4.030

4.  BK channel activation by NS11021 decreases excitability and contractility of urinary bladder smooth muscle.

Authors:  Jeffrey J Layne; Bernhard Nausch; Søren-Peter Olesen; Mark T Nelson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-11-18       Impact factor: 3.619

Review 5.  Electrophysiological properties of the bladder.

Authors:  C H Fry; C Wu; G P Sui
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1998

6.  Octodon degus, a new model to study the agonist and plexus-induced response in the urinary bladder.

Authors:  Francisco Eduardo Martin-Cano; Mercedes Caso-Agundez; Cristina Camello-Almaraz; Francisco Juan Santos; María Teresa Espin; Juan Antonio Madrid; Adolfo Diez-Perez; Pedro Javier Camello; Maria Jose Pozo
Journal:  J Physiol Biochem       Date:  2016-10-13       Impact factor: 4.158

7.  Nerve-released acetylcholine contracts urinary bladder smooth muscle by inducing action potentials independently of IP3-mediated calcium release.

Authors:  Bernhard Nausch; Thomas J Heppner; Mark T Nelson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-06-23       Impact factor: 3.619

8.  Modulation of purinergic neuromuscular transmission by phorbol dibutyrate is independent of protein kinase C in murine urinary bladder.

Authors:  T J Searl; E M Silinsky
Journal:  J Pharmacol Exp Ther       Date:  2012-04-30       Impact factor: 4.030

Review 9.  Purinergic signalling in the urinary tract in health and disease.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-11-22       Impact factor: 3.765

Review 10.  Pharmacological methods for the preclinical assessment of therapeutics for OAB: an up-to-date review.

Authors:  Emilio Sacco; Riccardo Bientinesi; Pierfrancesco Bassi; Diego Currò
Journal:  Int Urogynecol J       Date:  2016-02-17       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.